The Jerusalem PostIDF confirms vehicle struck in Gaza was used by PIJ terrorists, after claims they were aid workersBollywood HungamaSCOOP: Ajay Devgn and Bhushan Kumar in talks for a big-budget spy thriller; looks at 2028 releaseFootball ItaliaSerie A Liveblog: Como-Cagliari, Lazio-Lecce, Parma-Roma and Napoli-TorinoZDF heuteAktuelle Pressemitteilungen des ZDFSDP Espectáculos“Estamos cansados de la violencia”: Alejandro Speitzer tras captura de Chapo IsidroThe South AfricanSpringboks lose to Ireland, but reach Nations Championship ‘final’ESPN DeportesEl efecto Almada benefició a Erick Sánchez y Kevin ÁlvarezBBC عربيالخلاف حول الوقود الأحفوري يُعرقل محادثات مؤتمر المناخ "كوب 31"The IndependentHow Farage is ‘not dead yet’ and plotting his political comebackNU.nlBeruchte drugsbaron 'El Chapo Isidro' opgepakt na chaotische militaire operatieRadio-CanadaSPVM : arrestation de deux policiers récemment congédiésSudinfoSpectaculaire sur l’autoroute : à 90 ans, elle roule pendant 35 kilomètres à contresens !
The Daily Newsstand · Free, Always
Saturday, November 21, 2026

Obese Monkey Becomes a Weight-Loss Drug Guinea Pig in ‘Boltrim’ at India’s WAVES Film Bazaar

Translate

Director Ashish Aryan is presenting “Boltrim,” a Hindi-English dark comedy about an obese monkey subjected to drug trials by a pharmaceutical giant developing a weight-loss injection, to the Co-Production Market at India’s WAVES Film Bazaar.

The film traces the smuggled animal’s journey from Assam to a Delhi laboratory, exploring how far an operations manager at the trial agency will go to achieve the desired results.

An NFDC Screenwriters’ Lab alum (“T for Taj Mahal”), Aryan has previously produced and written the web series “Matka King” (Prime Video), and directed “Roti, Kapda & Internet” (“Bread, Butter & Internet”). The idea for “Boltrim” came from a news report about a global shortage of laboratory monkeys, which had driven prices up to $50,000 per animal.

“I was drawn to the disturbing intersection of two worlds – the smuggling and exploitation of animals in an increasingly lucrative clinical-trial industry, and our own obsession with bodily perfection, which a loss-making pharma company decides to capitalize on,” Aryan says. “Weight-loss injections meant to treat obesity and diabetes are now being widely used as a cosmetic shortcut. I want to explore how much cruelty we are willing to overlook in the pursuit of looking perfect.”

The Writers Cloud, Jugaad Motion Pictures and Mirage Films are attached to the project, with $320,000 of its $1.2 million budget secured. Producer Siddartha Jatla (Busan title “Love and Shukla”) says the team is seeking international co-production and platform partners in Europe and Asia.

The film is expected to enter pre-production in early 2027, with shooting planned for the first quarter of 2028. “If we find a partner at WAVES Film Bazaar, the timeline may change. Mirage Films has been part of three international co-productions, with collaborations involving China, the U.S., Taiwan, Indonesia, the Netherlands and Cambodia,” Jatla says.

Producer Dheer Momaya of Jugaad Motion Pictures, whose credits include India’s Oscar submission “Last Film Show,” says he was drawn to Aryan’s determination and the story’s emotional narrative, which he describes as an “honest reflection of our times.”

“It is challenging to raise finance for independent Indian films, given limited access to cultural and government funds,” Momaya says. “For ‘Last Film Show,’ we had Canal+ (France) come in with a distribution minimum guarantee and Stranger 88 (Belgium) with equity. We will explore similar strategic partnerships, as well as cultural and government funds in France, Germany and the Netherlands. We will also look at environmental conservation grants, as ‘Boltrim’ is a timely film about the dwindling natural habitat of humans and animals.”

WAVES Film Bazaar runs as the market component of the International Film Festival of India (IFFI) in Goa.

View the original on Variety →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.